Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions

• Marc Tänzer,

  Affiliation Department of Medicine II, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯
• Benjamin Balluff,

  Affiliation Department of Medicine II, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯
• Jürgen Distler,

  Affiliation Epigenomics Inc., Seattle, Washington, United States of America

  ⨯
• Kari Hale,

  Affiliation Epigenomics Inc., Seattle, Washington, United States of America

  ⨯
• Andreas Leodolter,

  Affiliation Department of Medicine, Jung-Stilling Krankenhaus, Siegen, Germany

  ⨯
• Christoph Röcken,

  Affiliation Institute of Pathology, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Bela Molnar,

  Affiliation Department of Medicine II, Semmelweis University, Budapest, Hungary

  ⨯
• Roland Schmid,

  Affiliation Department of Medicine II, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯
• Catherine Lofton-Day,

  Affiliation Epigenomics Inc., Seattle, Washington, United States of America

  ⨯
• Tibor Schuster,

  Affiliation Institute of Medical Statistics and Epidemiology, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯
• Matthias P. A. Ebert

  * E-mail: Matthias.Ebert@lrz.tum.de

  Affiliation Department of Medicine II, Klinikum rechts der Isar, Technische Universität, München, Germany

  ⨯